United States Environmental Protection Agency
Integrated Risk Information System Logo


Amitraz
CASRN 33089-61-1

Contents


0334
Amitraz; CASRN 33089-61-1  


Health assessment information on a chemical substance is included in IRIS only 
after a comprehensive review of chronic toxicity data by U.S. EPA health 
scientists from several Program Offices and the Office of Research and 
Development.  The summaries presented in Sections I and II represent a 
consensus reached in the review process.  Background information and 
explanations of the methods used to derive the values given in IRIS are 
provided in the Background Documents. 


STATUS OF DATA FOR  Amitraz

File On-Line 08/22/1988

Category (section)                           Status      Last Revised
-----------------------------------------    --------    ------------

Oral RfD Assessment (I.A.)                   on-line       12/01/1988

Inhalation RfC Assessment (I.B.)             no data     

Carcinogenicity Assessment (II.)             no data     



_I. CHRONIC HEALTH HAZARD ASSESSMENTS FOR NONCARCINOGENIC EFFECTS __I.A. REFERENCE DOSE FOR CHRONIC ORAL EXPOSURE (RfD) Substance Name -- Amitraz CASRN -- 33089-61-1 Primary Synonym -- BTS 27 419 Last Revised -- 12/01/1988 The oral Reference Dose (RfD) is based on the assumption that thresholds exist for certain toxic effects such as cellular necrosis. It is expressed in units of mg/kg-day. In general, the RfD is an estimate (with uncertainty spanning perhaps an order of magnitude) of a daily exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime. Please refer to the Background Document for an elaboration of these concepts. RfDs can also be derived for the noncarcinogenic health effects of substances that are also carcinogens. Therefore, it is essential to refer to other sources of information concerning the carcinogenicity of this substance. If the U.S. EPA has evaluated this substance for potential human carcinogenicity, a summary of that evaluation will be contained in Section II of this file. ___I.A.1. ORAL RfD SUMMARY Critical Effect Experimental Doses* UF MF RfD -------------------- ----------------------- ----- --- --------- Increased mean blood NOEL: 0.25 mg/kg/day 100 1 2.5E-3 sugar concentration; mg/kg/day slight hypothermia LEL: 1.0 mg/kg/day 2-Year Dog Oral Feeding Study Upjohn Co., 1972a
*Conversion Factors: 1 ppm = 0.025 mg/kg/day (assumed dog food consumption) ___I.A.2. PRINCIPAL AND SUPPORTING STUDIES (ORAL RfD) Upjohn Company. 1972a. MRID No. 00030493, 00040856. Available from EPA. Write to FOI, EPA, Washington, DC 20460. Groups of 8 beagle dogs (4/sex/dose level) were given 0.1, 0.25, and 1 mg/kg/day of amitraz for 2 years. All eight dogs given 1 mg/kg/day exhibited signs of slight CNS depression 3 hours after dosing on days 1 and 2, and all appeared normal again by the following morning. One male receiving 1 mg/kg/day had a slight subnormal temperature at 3 hours which returned to normal within 24 hours. All dogs in this group appeared clinically normal, except one female that was slightly hypothermic 3 hours after dosing during weeks 52 and 79. Blood samples were collected during weeks 40 and 53 showed significant increase in mean blood sugar concentration 3 hours after dosing in the 1 mg/kg/day group. No clinical reactions to treatment were seen in dogs at lower dosages. ___I.A.3. UNCERTAINTY AND MODIFYING FACTORS (ORAL RfD) UF -- An uncertainty factor of 100 was used, 10 each to account for the inter- and intraspecies differences. MF -- None ___I.A.4. ADDITIONAL COMMENTS (ORAL RfD) Data Considered for Establishing the RfD 1) 2-Year Feeding - dog: Principal study - see previous description; core grade minimum 2) 2-Year Feeding - rat: Systemic NOEL=50 ppm (2.5 mg/kg/day); Systemic LEL=200 ppm (10 mg/kg/day) (HDT; temporarily depressed food intake, depressed growth rate, nervous, aggressive, excitable); core grade minimum (Upjohn Co., 1973a) 3) 3-Generation Reproduction - rat: NOEL=15 ppm (1.6 mg/kg/day); Systemic LEL=50 ppm (5 mg/kg/day (increase mortality during suckling period; decreased litter size); core grade minimum (Boots Hercules Agrochemicals Co., 1980) 4) Teratology - rat: NOEL=12 mg/kg/day (HDT); core grade minimum (Upjohn Co., 1973b) 5) Teratology - rabbit: Teratogenic NOEL=25 mg/kg/day (frank maternal toxicity at higher levels precluded a teratogenic assessment); Maternal NOEL=25 mg/kg/day; Maternal LEL=50 mg/kg/day (mortality); Fetotoxic NOEL=25 mg/kg/day; Fetotoxic LEL=50 mg/kg/day (mortality); no core grade (Boots Hercules Agrochemicals Co., 1973) 6) Teratology - rabbit: Teratogenic NOEL=25 mg/kg/day (HDT); Teratogenic LEL=none; Fetotoxic NOEL=1 mg/kg/day; Fetotoxic LEL=5 mg/kg/day (one cleft palate, meningocoele associated with small ears and displaced toe); no core grade (Upjohn Co., 1973c) Other Data Reviewed: 1) 90-Day Feeding - dog: NOEL=0.25 mg/kg/day; LEL=1 mg/kg/day (CNS depression, decreased rectal temperature, decreased pulse, increased blood sugar, neutrophilia in bone marrow, slight enlargement of central and midzonal hepatocytes, hyperplasia of zona glomerulosa with decrease in zona fasiculata and reticularis); core grade minimum (Upjohn Co., 1973d) 2) 90-Day Feeding - rat: NOEL=3 mg/kg/day; LEL=12 mg/kg/day (depressed body weight gain, increased brain to body weight ratio); core grade supplementary (Upjohn Co., 1971) 3) 90-Day Feeding - mouse: NOEL=3 mg/kg/day; LEL=12 mg/kg/day (decreased body weight gain, increased heart weight); core grade minimum (Upjohn Co., 1972b) Data Gap(s): None ___I.A.5. CONFIDENCE IN THE ORAL RfD Study -- Medium Data Base -- Medium RfD -- Medium The critical study is of adequate quality and is given a medium confidence rating. Additional studies are supportive and of fair quality and therefore the data base is given a medium confidence rating. Medium confidence in the RfD follows. ___I.A.6. EPA DOCUMENTATION AND REVIEW OF THE ORAL RfD Source Document -- This assessment is not presented in any existing U.S. EPA document. Other EPA Documentation -- Pesticide Registration Files Agency Work Group Review -- 10/14/1987 Verification Date -- 10/14/1987 ___I.A.7. EPA CONTACTS (ORAL RfD) Please contact the Risk Information Hotline for all questions concerning this assessment or IRIS, in general, at (513)569-7254 (phone), (513)569-7159 (FAX) or RIH.IRIS@EPAMAIL.EPA.GOV (internet address).
__I.B. REFERENCE CONCENTRATION FOR CHRONIC INHALATION EXPOSURE (RfC) Substance Name -- Amitraz CASRN -- 33089-61-1 Primary Synonym -- BTS 27 419 Not available at this time.
_II. CARCINOGENICITY ASSESSMENT FOR LIFETIME EXPOSURE Substance Name -- Amitraz CASRN -- 33089-61-1 Primary Synonym -- BTS 27 419 This substance/agent has not undergone a complete evaluation and determination under US EPA's IRIS program for evidence of human carcinogenic potential.
_VI. BIBLIOGRAPHY Substance Name -- Amitraz CASRN -- 33089-61-1 Primary Synonym -- BTS 27 419 Last Revised -- 10/01/1989 __VI.A. ORAL RfD REFERENCES Boots Hercules Agrochemicals Company. 1973. MRID No. 00029961. Available from EPA. Write to FOI, EPA, Washington D.C. 20460. Boots Hercules Agrochemicals Company. 1980. MRID No. 00029960, 00029962. Available from EPA. Write to FOI, EPA, Washington D.C. 20460. Upjohn Company. 1971. MRID No. 00051784. Available from EPA. Write to FOI, EPA, Washington D.C. 20460. Upjohn Company. 1972a. MRID No. 00030493, 00040856. Available from EPA. Write to FOI, EPA, Washington D.C. 20460. Upjohn Company. 1972b. MRID No. 00072818, 00133930. Available from EPA. Write to FOI, EPA, Washington D.C. 20460. Upjohn Company. 1973a. MRID No. 00041197, 00044585. Available from EPA. Write to FOI, EPA, Washington D.C. 20460. Upjohn Company. 1973b. MRID No. 00040856. Available from EPA. Write to FOI, EPA, Washington D.C. 20460. Upjohn Company. 1973c. MRID No. 00040860. Available from EPA. Write to FOI, EPA, Washington D.C. 20460. Upjohn Company. 1973d. MRID No. 00040345. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.
__VI.B. INHALATION RfD REFERENCES None
__VI.C. CARCINOGENICITY ASSESSMENT REFERENCES None
_VII. REVISION HISTORY Substance Name -- Amitraz CASRN -- 33089-61-1 Primary Synonym -- BTS 27 419 -------- -------- -------------------------------------------------------- Date Section Description -------- -------- -------------------------------------------------------- 08/22/1988 I.A. Oral RfD summary on-line 12/01/1988 I.A.4. Core grades corrected 10/01/1989 VI. Bibliography on-line 01/01/1992 IV. Regulatory Action section on-line
VIII. SYNONYMS Substance Name -- Amitraz CASRN -- 33089-61-1 Primary Synonym -- BTS 27 419 Last Revised -- 08/22/1988 33089-61-1 Amitraz amitraze amitraz estrella azadieno BAAM Boots BTS 27419 BTS 27 419 1,5-di(2,4-dimethylphenyl-3-methyl-1,3,5-triazapenta-1,4-diene ENT 27967 methanimidamide, N'-(2,4-dimethylphenyl)-N-(((2,4-dimethylphenyl)imino)methyl) -N-methyl- 2-methyl-1,3-di(2,4-xylylimino)-2-azapropane mitaban mitac N'-(2,4-dimethylphenyl)-N-(((2,4-dimethylphenyl)imino)methyl)-N- methylmethanimidamide N-methyl-bis(2,4-xylyliminomethyl)amine N-methyl-N'-2,4-xylyl-N-(N-2,4-xylylformimidoyl)formamidine N,N-bis(2,4-xylyliminomethyl)methylamine N,N-di-(2,4-xylyliminomethyl)methylamine N,N'-((methylimino)dimethylidyne)di-2,4-xylidine R.D. 27419 taktic triatox U-36059 Upjohn U-36059 2,4-xylidine, N,N'-(methyliminodimethylidyne)bis-



IRIS Home Page Substance File List
Comments on the IRIS web site Search the IRIS database National Center for Environmental Assessment Office of Research and Development's Home Page EPA's Home Page


Last updated: 5 May 1998
URL: http://www.epa.gov/iris/SUBST/0334.HTM